175 related articles for article (PubMed ID: 9774443)
1. Identification of limiting steps for efficient trans-activation of HIV-1 promoter by Tat in Saccharomyces cerevisiae.
Daviet L; Bois F; Battisti PL; Gatignol A
J Biol Chem; 1998 Oct; 273(43):28219-28. PubMed ID: 9774443
[TBL] [Abstract][Full Text] [Related]
2. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1.
Kamine J; Chinnadurai G
J Virol; 1992 Jun; 66(6):3932-6. PubMed ID: 1583736
[TBL] [Abstract][Full Text] [Related]
4. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
Berkhout B; Jeang KT
J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
[TBL] [Abstract][Full Text] [Related]
5. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function.
Huang LM; Jeang KT
J Virol; 1993 Dec; 67(12):6937-44. PubMed ID: 8230415
[TBL] [Abstract][Full Text] [Related]
6. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
Ghosh S; Selby MJ; Peterlin BM
J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
[TBL] [Abstract][Full Text] [Related]
7. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment.
Xiao H; Lis JT; Jeang KT
Mol Cell Biol; 1997 Dec; 17(12):6898-905. PubMed ID: 9372921
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
Majello B; Napolitano G; Lania L
AIDS; 1998 Oct; 12(15):1957-64. PubMed ID: 9814863
[TBL] [Abstract][Full Text] [Related]
9. Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.
Carruth LM; Hardwick JM; Morse BA; Clements JE
J Virol; 1994 Oct; 68(10):6137-46. PubMed ID: 8083955
[TBL] [Abstract][Full Text] [Related]
10. Delineating minimal protein domains and promoter elements for transcriptional activation by lentivirus Tat proteins.
Southgate CD; Green MR
J Virol; 1995 Apr; 69(4):2605-10. PubMed ID: 7884911
[TBL] [Abstract][Full Text] [Related]
11. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
12. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
Majello B; De Luca P; Hagen G; Suske G; Lania L
Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
[TBL] [Abstract][Full Text] [Related]
13. The activation region of the Tat protein of human immunodeficiency virus type-1 functions in yeast.
Subramanian T; D'Sa-Eipper C; Elangovan B; Chinnadurai G
Nucleic Acids Res; 1994 Apr; 22(8):1496-9. PubMed ID: 8190642
[TBL] [Abstract][Full Text] [Related]
14. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
15. Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1.
Kim YS; Kim JM; Jung DL; Kang JE; Lee S; Kim JS; Seol W; Shin HC; Kwon HS; Van Lint C; Hernandez N; Hur MW
J Biol Chem; 2005 Jun; 280(22):21545-52. PubMed ID: 15743774
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
Chang LJ; McNulty E; Martin M
J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
[TBL] [Abstract][Full Text] [Related]
17. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
19. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat.
Lu X; Welsh TM; Peterlin BM
J Virol; 1993 Apr; 67(4):1752-60. PubMed ID: 8445708
[TBL] [Abstract][Full Text] [Related]
20. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
Veschambre P; Simard P; Jalinot P
J Mol Biol; 1995 Jul; 250(2):169-80. PubMed ID: 7608968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
